Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Differential in vitro effects of targeted therapeutics in primary human liver cancer: importance for combined liver cancer

Fig. 6

Proliferation studies of ICC (HUH28, RBE, SSP25, a-c, ECC (EGI1, CCC5, TFK1, d-f and HCC/hepatoblastoma (HEP3B, HUH7, HEPG2, g-i cell lines. Effects of Rapamycin (Rapa) after 0, 24, 48, 72 and 96 h (h). 0 h values were set to 100%. Concentrations of Rapamycin are indicated. Shown are the mean values of n = 3–5 independent experiments with each 6–8 replicates. Controls were treated with solvent (DMSO). Significance was tested by one-way ANOVA between the control and treatment groups. *p < 0.05, **p < 0.01, ***p < 0.001 with 95% level of confidence

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us